Drug use in acute meningococcal disease.
Cathie
K
K
University of Southampton Wellcome Trust Clinical Research Facility, Southampton University Hospital NHS Trust, Southampton, UK.
Levin
M
M
Faust
S N
SN
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use*; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005440:Fluid Therapy; D006801:Humans; D019586:Intracranial Hypertension / Q000209:etiology; D008585:Meningitis, Meningococcal / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000627:therapeutic use; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology
D000900:Anti-Bacterial Agents; C094429:Mencevax AC; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; D002439:Cefotaxime